News
DelveInsight's“ Obesity Pipeline Insigh t 2025 ” report provides comprehensive insights about 80+ companies and 100+ pipeline ...
North East and North Cumbria NHS has begun a year-long rollout of the Healthinote digital health platform to support patients ...
Pioneer in RNA research who gave children with SMA a future Sabine Löwer Communications Boehringer Ingelheim St ...
In a significant push to address one of the Philippines’ most pressing but underrecognized public health issues, the German-Philippine Chamber of Commerce and Industry (GPCCI), the German Embassy ...
Boehringer Ingelheim & LEO Pharma partner to commercialize and further develop Spevigo: Ingelheim, Germany Wednesday, July 16, 2025, 15:00 Hrs [IST] Boehringer Ingelheim, a biopha ...
Boehringer Ingelheim and SoundTalks end their partnership, but what does this mean for pig farmers? Find out about the future ...
Boehringer Ingelheim set to receive EUR 90 million as upfront payment, along with milestone payments and tiered royalties.
Steatotic liver disease often progresses asymptomatically, with the risk of advancing to cirrhosis and liver cancer. Early ...
BI 1815368, a potential oral treatment to improve vision in patients with diabetic macular edema, is being investigated in a ...
LEO Pharma acquires global rights to Spevigo for $105M, boosting its dermatology pipeline and expanding access for patients ...
LEO has plans for Spevigo beyond generalised pustular psoriasis as it looks to boost its dermatological pipeline.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results